OnCo

Create your OnCo account

One account keeps your watchlist, saved views and cancer choice in sync across your devices, and lets OnCo alert you when a trial or treatment you follow changes. No password: we email you a sign-in link.

Account creation is being switched on. Until then, press Watch on any page and your list stays in this browser.

Appointment sheet: High-grade serous ovarian cancer

One page to bring and write on: your details, the questions for High-grade serous ovarian cancer plus your own, the words you may hear, what to bring, the treatments the standard of care names, and room for the answers and agreed next steps. What you type stays in this browser. Print it or save it as a PDF. New to all this? Start with the first 60 days. Orientation, not medical advice.

Tick the questions to print

All of this cancer's questions start ticked. Untick what does not apply; ticks are kept in this browser. .

Your own questions

Shared with the prep pack, so questions you add there appear here too.

Print or save as PDF

Use (or Ctrl+P, Cmd+P on a Mac). To keep a copy, choose Save as PDF as the destination in the print dialog. Only the sheet prints; the controls stay on screen. Your typed notes print where you typed them; empty fields print as ruled lines to write on.

Appointment sheet

High-grade serous ovarian cancer

Prepared with OnCo (onco.cc/prep/high-grade-serous-ovarian-cancer/). Orientation, not medical advice; your team knows your case.

My details

Name
Date of appointment
Hospital and clinician
Who is coming with me

What I know, what is unclear, changes to discuss

Saved in this browser
What I know so far
What is unclear to me
Changes since last time

My questions

20 on the sheet
Newly diagnosed
  1. 1.What is my exact diagnosis, stage, and grade, and which tests established them?
  2. 2.Which biomarkers have been tested on my tumour (for example TP53 mutation, Germline and somatic BRCA1/2, HRD score, Folate receptor alpha, CA-125 for monitoring), and what were the results?
  3. 3.Which subtype is my cancer, and does that change the recommended treatment?
  4. 4.Is germline (inherited) genetic testing recommended for me or my family?
First line
  1. 5.For my situation (first line), which of the standard options do you recommend and why?
  2. 6.Am I a candidate for Carboplatin, Paclitaxel / nab-paclitaxel, Bevacizumab, and what side effects should I expect?
Maintenance after first line
  1. 7.For my situation (maintenance after first line), which of the standard options do you recommend and why?
  2. 8.Am I a candidate for Olaparib, Niraparib, and what side effects should I expect?
  3. 9.How do the results of SOLO-1 and PRIMA / ENGOT-OV26 apply to someone like me?
Platinum-sensitive relapse
  1. 10.For my situation (platinum-sensitive relapse), which of the standard options do you recommend and why?
  2. 11.Am I a candidate for Rucaparib, Niraparib, and what side effects should I expect?
  3. 12.How do the results of DESKTOP III / ENGOT-ov20 apply to someone like me?
Platinum-resistant relapse
  1. 13.For my situation (platinum-resistant relapse), which of the standard options do you recommend and why?
  2. 14.Am I a candidate for Mirvetuximab soravtansine, Relacorilant, Bevacizumab, and what side effects should I expect?
Prevention in carriers
  1. 15.For my situation (prevention in carriers), which of the standard options do you recommend and why?
Any stage
  1. 16.Are there clinical trials I could join, for example of Mirvetuximab soravtansine, Relacorilant, Folate receptor alpha?
  2. 17.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
  3. 18.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
  4. 19.I read that “No screening test lowers mortality”. How does that affect my plan?
  5. 20.I read that “Homologous recombination proficient tumours gain little from PARP inhibitors”. How does that affect my plan?

The words I may hear

Tests and results to bring

Biomarker results to ask for: TP53 mutation (universal), Germline and somatic BRCA1/2, HRD score (Myriad myChoice or equivalent), Folate receptor alpha (mirvetuximab), CA-125 for monitoring, Platinum-free interval.

Scans and tests linked to this cancer: HRD genomic scar scores (GIS, LOH, HRDetect), RAD51 foci assay (functional HRD test).

Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.

The treatments I may be offered

From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.

Answers and next steps

Saved in this browser
What I was told
Agreed next steps, dates and who to call